These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. Survival in individuals with severe alpha 1-antitrypsin deficiency (PiZZ) in comparison to a general population with known smoking habits. Tanash HA, Ekström M, Rönmark E, Lindberg A, Piitulainen E. Eur Respir J; 2017 Sep; 50(3):. PubMed ID: 28889108 [Abstract] [Full Text] [Related]
15. Lung Function and CT Densitometry in Subjects with alpha-1-Antitrypsin Deficiency and Healthy Controls at 35 Years of Age. Piitulainen E, Montero LC, Nystedt-Düzakin M, Stoel BC, Sveger T, Wollmer P, Tanash HA, Diaz S. COPD; 2015 Apr; 12(2):162-7. PubMed ID: 25280185 [Abstract] [Full Text] [Related]
16. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ). Piitulainen E, Eriksson S. Eur Respir J; 1999 Feb; 13(2):247-51. PubMed ID: 10065663 [Abstract] [Full Text] [Related]
17. Asthma features in severe alpha1-antitrypsin deficiency: experience of the National Heart, Lung, and Blood Institute Registry. Eden E, Hammel J, Rouhani FN, Brantly ML, Barker AF, Buist AS, Fallat RJ, Stoller JK, Crystal RG, Turino GM. Chest; 2003 Mar; 123(3):765-71. PubMed ID: 12628876 [Abstract] [Full Text] [Related]